INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
INVO Fertility, Inc. (IVF)
Company Research
Source: GlobeNewswire
SARASOTA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced the final issuance of a U.S. patent covering a modified version of its proprietary INVOcell® device. The patent (U.S. Patent No. 12,544,204 B2) became effective on February 10, 2026, providing intellectual property protection on the INVOcell device through 2040. INVOcell is the world’s first FDA-cleared intravaginal culture (IVC) system—a patented medical device for assisted reproductive care that allows fertilization and early embryo development to take place within a woman’s body, offering a more natural and patient-centered alternative to traditional in vitro fertilization (IVF). INVOcell was initially granted FDA clearance in 2015 and, in 2023, received additional FDA clearance for a labeling update that
Show less
Read more
Impact Snapshot
Event Time:
IVF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IVF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IVF alerts
High impacting INVO Fertility, Inc. news events
Weekly update
A roundup of the hottest topics
IVF
News
- INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”GlobeNewswire
- INVO Fertility (NASDAQ:IVF) was upgraded by analysts at Maxim Group from a "hold" rating to a "strong-buy" rating.MarketBeat
- INVO Fertility (NASDAQ:IVF) was given a new $4.00 price target on by analysts at Maxim Group.MarketBeat
- INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for GrowthGlobeNewswire
- INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq RulesGlobeNewswire
IVF
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/12/26 - Form 424B3
- 2/11/26 - Form EFFECT
- IVF's page on the SEC website